LIFEMD INC (LFMD) Fundamental Analysis & Valuation
NASDAQ:LFMD • US53216B1044
3.12 USD
+0.21 (+7.22%)
At close: Mar 4, 2026
3.12 USD
0 (0%)
After Hours: 3/4/2026, 8:00:03 PM
This LFMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Taking everything into account, LFMD scores 3 out of 10 in our fundamental rating. LFMD was compared to 35 industry peers in the Health Care Technology industry. LFMD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LFMD is quite expensive at the moment. It does show a decent growth rate.
1. LFMD Profitability Analysis
1.1 Basic Checks
- In the past year LFMD has reported negative net income.
- In the past year LFMD had a positive cash flow from operations.
- LFMD had negative earnings in each of the past 5 years.
- In multiple years LFMD reported negative operating cash flow during the last 5 years.
1.2 Ratios
- LFMD has a Return On Assets (-11.68%) which is comparable to the rest of the industry.
- LFMD has a Return On Equity of -586.53%. This is amonst the worse of the industry: LFMD underperforms 85.71% of its industry peers.
- LFMD has a better Return On Invested Capital (5.81%) than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.68% | ||
| ROE | -586.53% | ||
| ROIC | 5.81% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Operating Margin, with a value of 0.27%, LFMD is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
- LFMD has a Gross Margin of 86.96%. This is amongst the best in the industry. LFMD outperforms 91.43% of its industry peers.
- LFMD's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.27% | ||
| PM (TTM) | N/A | ||
| GM | 86.96% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. LFMD Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LFMD is destroying value.
- LFMD has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, LFMD has more shares outstanding
- The debt/assets ratio for LFMD has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -0.29, we must say that LFMD is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -0.29, LFMD is in line with its industry, outperforming 45.71% of the companies in the same industry.
- LFMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | -0.29 |
ROIC/WACC0.57
WACC10.15%
2.3 Liquidity
- LFMD has a Current Ratio of 0.73. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
- LFMD's Current ratio of 0.73 is on the low side compared to the rest of the industry. LFMD is outperformed by 82.86% of its industry peers.
- A Quick Ratio of 0.66 indicates that LFMD may have some problems paying its short term obligations.
- LFMD's Quick ratio of 0.66 is on the low side compared to the rest of the industry. LFMD is outperformed by 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.66 |
3. LFMD Growth Analysis
3.1 Past
- LFMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.13%, which is quite impressive.
- The Revenue has grown by 30.71% in the past year. This is a very strong growth!
- The Revenue has been growing by 76.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)30.71%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
3.2 Future
- The Earnings Per Share is expected to grow by 18.36% on average over the next years. This is quite good.
- LFMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.16% yearly.
EPS Next Y61.09%
EPS Next 2Y37.18%
EPS Next 3Y34.41%
EPS Next 5Y18.36%
Revenue Next Year15.11%
Revenue Next 2Y4.37%
Revenue Next 3Y8.63%
Revenue Next 5Y3.16%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. LFMD Valuation Analysis
4.1 Price/Earnings Ratio
- LFMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year LFMD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LFMD indicates a somewhat cheap valuation: LFMD is cheaper than 80.00% of the companies listed in the same industry.
- The rest of the industry has a similar Price/Free Cash Flow ratio as LFMD.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 608.08 | ||
| EV/EBITDA | 10.8 |
4.3 Compensation for Growth
- LFMD's earnings are expected to grow with 34.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.18%
EPS Next 3Y34.41%
5. LFMD Dividend Analysis
5.1 Amount
- LFMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
LFMD Fundamentals: All Metrics, Ratios and Statistics
3.12
+0.21 (+7.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-17 2025-11-17/amc
Earnings (Next)03-09 2026-03-09/amc
Inst Owners43.01%
Inst Owner Change-9.27%
Ins Owners17.81%
Ins Owner Change0.25%
Market Cap150.20M
Revenue(TTM)252.34M
Net Income(TTM)-7.71M
Analysts81.43
Price Target9.44 (202.56%)
Short Float %14.46%
Short Ratio5.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-40.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-341.17%
Min EPS beat(2)-635.29%
Max EPS beat(2)-47.05%
EPS beat(4)2
Avg EPS beat(4)-125.48%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-71.45%
EPS beat(12)4
Avg EPS beat(12)-68.84%
EPS beat(16)5
Avg EPS beat(16)-56.76%
Revenue beat(2)0
Avg Revenue beat(2)-6.5%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)-4.95%
Revenue beat(4)2
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.29%
Revenue beat(12)7
Avg Revenue beat(12)-0.23%
Revenue beat(16)7
Avg Revenue beat(16)-1.53%
PT rev (1m)0%
PT rev (3m)-28.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)33.34%
EPS NY rev (1m)0%
EPS NY rev (3m)-50.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.6 | ||
| P/FCF | 608.08 | ||
| P/OCF | 11.44 | ||
| P/B | 114.27 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.8 |
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.01
FCFY0.16%
OCF(TTM)0.27
OCFY8.74%
SpS5.24
BVpS0.03
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.68% | ||
| ROE | -586.53% | ||
| ROCE | 7.35% | ||
| ROIC | 5.81% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 0.27% | ||
| PM (TTM) | N/A | ||
| GM | 86.96% | ||
| FCFM | 0.1% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 116.91% | ||
| Cap/Sales | 5.1% | ||
| Interest Coverage | 0.33 | ||
| Cash Conversion | 112.17% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | -0.29 |
F-Score5
WACC10.15%
ROIC/WACC0.57
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y61.09%
EPS Next 2Y37.18%
EPS Next 3Y34.41%
EPS Next 5Y18.36%
Revenue 1Y (TTM)30.71%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
Revenue Next Year15.11%
Revenue Next 2Y4.37%
Revenue Next 3Y8.63%
Revenue Next 5Y3.16%
EBIT growth 1Y103.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.85%
EBIT Next 3Y55.58%
EBIT Next 5Y43.22%
FCF growth 1Y103.53%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y1051.68%
OCF growth 3YN/A
OCF growth 5Y133.93%
LIFEMD INC / LFMD FAQ
What is the ChartMill fundamental rating of LIFEMD INC (LFMD) stock?
ChartMill assigns a fundamental rating of 3 / 10 to LFMD.
What is the valuation status for LFMD stock?
ChartMill assigns a valuation rating of 2 / 10 to LIFEMD INC (LFMD). This can be considered as Overvalued.
What is the profitability of LFMD stock?
LIFEMD INC (LFMD) has a profitability rating of 3 / 10.
How financially healthy is LIFEMD INC?
The financial health rating of LIFEMD INC (LFMD) is 4 / 10.